<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000635736"><TermName>BEACOPP</TermName><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat advanced Hodgkin lymphoma. It includes the drugs bleomycin sulfate, etoposide phosphate, doxorubicin hydrochloride (Adriamycin), cyclophosphamide, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone. Also called BEACOPP regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000734653" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;BEACOPP&quot;" language="en" id="_3"/><SpanishTermName>BEACOPP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de  una quimioterapia combinada que se usa para tratar el linfoma de Hodgkin en estadio avanzado. Incluye los siguientes medicamentos: sulfato de bleomicina, fosfato de etopósido, clorhidrato de doxorubicina (Adriamicina), ciclofosfamida,  sulfato de vincristina (Oncovin), clorhidrato de procarbazina y prednisona. También se llama régimen BEACOPP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-02-20</DateFirstPublished><DateLastModified>2010-05-05</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000632570">BEACOPP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
